Nurix Stock Price Targets Lowered by Analysts Amid Financial Concerns
Nurix has faced a significant downgrade in stock price targets, with Stifel lowering it to $33 and Leerink Partners to $12. These adjustments highlight rising expenses and concerns about the company's financial health and market position, potentially affecting investor confidence and future growth prospects.
Nurix Stock Price Targets Lowered by Analysts Amid Financial Concerns
Nurix has faced a significant downgrade in stock price targets, with Stifel lowering it to $33 and Leerink Partners to $12. These adjustments highlight rising expenses and concerns about the company's financial health and market position, potentially affecting investor confidence and future growth prospects.
Why World Pulse Now
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system has analyzed 5,110 articles worldwide
~212 per hour
580 trending stories shaping headlines
From breaking news to viral moments
Monitoring 198 trusted sources
Major outlets & specialized publications
Latest update 12 minutes ago
Always fresh